Kyntra Bio (KYNB) Current Deferred Revenue (2014 - 2026)
Kyntra Bio (KYNB) posted Current Deferred Revenue of $5.42 million for Q2 2026, down 80.2% from $27.31 million a year earlier and down 4.6% from the prior quarter.
Kyntra Bio (KYNB) Current Deferred Revenue (2014 - 2026) Analysis & Trends
At the end of FY2025, Kyntra Bio's Current Deferred Revenue came in at $5.31 million, down 80.5% from FY2024.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of -4.1% (FY2020 to FY2025).
- In prior years, Kyntra Bio's Current Deferred Revenue was $27.29 million in FY2024 (+114.2%), $12.74 million in FY2023 (unchanged), $12.74 million in FY2022 (-19.7%) and $15.86 million in FY2021 (+142.2%).
- Quarterly Current Deferred Revenue has run from a low of $4.74 million in Q1 2022 to a high of $28.86 million in Q3 2024 over five years.
- On a year-over-year basis, Current Deferred Revenue has declined in each of the last four quarters, with growth averaging 43.9% over the last eight quarters.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q3 2024, with growth of 294.0%; the weakest was Q3 2025, with a decline of 82.3%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $5.68 million (Q1 2026), $5.31 million (Q4 2025) and $5.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Kyntra Bio | 21.25 Mn | -386.69 Mn | 1.47 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.42 Mn |
| Mar 31, 2026 | 5.68 Mn |
| Dec 31, 2025 | 5.31 Mn |
| Sep 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | 27.31 Mn |
| Mar 31, 2025 | 22.51 Mn |
| Dec 31, 2024 | 27.29 Mn |
| Sep 30, 2024 | 28.86 Mn |
| Jun 30, 2024 | 9.55 Mn |
| Mar 31, 2024 | 12.86 Mn |
| Dec 31, 2023 | 12.74 Mn |
| Sep 30, 2023 | 7.33 Mn |
| Jun 30, 2023 | 7.49 Mn |
| Mar 31, 2023 | 16.50 Mn |
| Dec 31, 2022 | 12.74 Mn |
| Sep 30, 2022 | 7.36 Mn |
| Jun 30, 2022 | 6.90 Mn |
| Mar 31, 2022 | 4.74 Mn |
| Dec 31, 2021 | 15.86 Mn |
| Sep 30, 2021 | 23.26 Mn |
Kyntra Bio Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=KYNB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "KYNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=KYNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();